Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
Outcomes for patients with hematologic malignancy infected with COVID-19 have not been
aggregated. The objective of this study was to perform a systematic review and meta …
aggregated. The objective of this study was to perform a systematic review and meta …
[HTML][HTML] Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
B Asselain, W Barlow, J Bartlett, J Bergh… - The Lancet …, 2018 - thelancet.com
Background Neoadjuvant chemotherapy (NACT) for early breast cancer can make breast-
conserving surgery more feasible and might be more likely to eradicate micrometastatic …
conserving surgery more feasible and might be more likely to eradicate micrometastatic …
[PDF][PDF] Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer
Gallen (Switzerland) meeting in 2003 emphasizes new information that has emerged during
the 2 years since the seventh meeting in 2001. This article should be read in conjunction …
the 2 years since the seventh meeting in 2001. This article should be read in conjunction …
[HTML][HTML] Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early …
Abstract The 12th St Gallen International Breast Cancer Conference (2011) Expert Panel
adopted a new approach to the classification of patients for therapeutic purposes based on …
adopted a new approach to the classification of patients for therapeutic purposes based on …
[HTML][HTML] Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early …
A Goldhirsch, EP Winer, AS Coates, RD Gelber… - Annals of oncology, 2013 - Elsevier
Abstract The 13th St Gallen International Breast Cancer Conference (2013) Expert Panel
reviewed and endorsed substantial new evidence on aspects of the local and regional …
reviewed and endorsed substantial new evidence on aspects of the local and regional …
Growth hormone receptor and serum binding protein: purification, cloning and expression
DW Leung, SA Spencer, G Cachianes, RG Hammonds… - Nature, 1987 - nature.com
A putative growth hormone receptor from rabbit liver and the growth hormone binding
protein from rabbit serum have the same ammo-terminal amino-acid sequence, indicating …
protein from rabbit serum have the same ammo-terminal amino-acid sequence, indicating …
Identification of Heregulin, a Specific Activator of p185erbB2
WE Holmes, MX Sliwkowski, RW Akita, WJ Henzel… - Science, 1992 - science.org
The proto-oncogene designated erb B2 or HER2 encodes a 185-kilodalton transmembrane
tyrosine kinase (p185 erb B2), whose overexpression has been correlated with a poor …
tyrosine kinase (p185 erb B2), whose overexpression has been correlated with a poor …
Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
JP Sheridan, SA Marsters, RM Pitti, A Gurney… - Science, 1997 - science.org
TRAIL (also called Apo2L) belongs to the tumor necrosis factor family, activates rapid
apoptosis in tumor cells, and binds to the death-signaling receptor DR4. Two additional …
apoptosis in tumor cells, and binds to the death-signaling receptor DR4. Two additional …
Structure and functional expression of a human interleukin-8 receptor
WE Holmes, J Lee, WJ Kuang, GC Rice, WI Wood - Science, 1991 - science.org
Interleukin-8 (IL-8) is a member of a family of pro-inflammatory cytokines. Although the best
characterized activities of IL-8 include the chemoattraction and activation of neutrophils …
characterized activities of IL-8 include the chemoattraction and activation of neutrophils …
[HTML][HTML] Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer
Background The recurrence score based on the 21-gene breast cancer assay predicts
chemotherapy benefit if it is high and a low risk of recurrence in the absence of …
chemotherapy benefit if it is high and a low risk of recurrence in the absence of …